Dermatologicals in Argentina

September 2023 | 22 pages | ID: DF3A9E1908BEN
Euromonitor International Ltd

Abstracts

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which could lead to skin conditions. With a return to pre-pandemic lifestyles, there was an increased risk of dermatological problems, which supported support a higher need for specialised products.

Euromonitor International's Dermatologicals in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Dermatologicals market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

DERMATOLOGICALS IN ARGENTINA
KEY DATA FINDINGS
2023 DEVELOPMENTS
Increase in demand for dermatologicals, in keeping with normalisation of consumer lifestyles
Antiparasitics see dynamic performance, driven by new product development
Laboratorios Phoenix leads sales, supported by Pervinox brand
PROSPECTS AND OPPORTUNITIES
Further growth expected for dermatologicals, supported by the return of in-store displays
Further expansion anticipated in hair loss treatments
Online sales are predicted to continue improving in the coming years
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2018-2023
Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 6 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN ARGENTINA
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 9 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2018-2023
Table 11 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 12 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 13 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources